MONARCH 1, a Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients With Refractory HR + /HER2 − Metastatic Breast Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-0754
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Longitudinal Investigation of the Relationships Between Patient-Reported Symptoms and Survival Among Patients With HR+/HER2- Metastatic Breast Cancer (MBC) Treated With Abemaciclib in the Phase 2 Monarch 1 Trial

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Real-World Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis

Scientific Reports
Multidisciplinary
2019English

Everolimus-Based Therapy Versus Chemotherapy Among Patients With HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness From a Chart Review Study

International Journal of Breast Cancer
Cancer ResearchOncologyPharmacology
2015English

Emerging Data and Future Directions for CDK4/6 Inhibitor Treatment of Patients With Hormone Receptor Positive HER2-non-amplified Metastatic Breast Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

A Phase II Study of Gemcitabine Monotherapy in Breast Cancer Patients Refractory to Anthracycline and Taxane

Cancer Research and Treatment
Cancer ResearchOncology
2002English

Phase II Study of Pembrolizumab and Capecitabine for Triple Negative and Hormone Receptor-Positive, HER2−negative Endocrine-Refractory Metastatic Breast Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

S‐1 Plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial

Oncologist
Cancer ResearchMedicineOncology
2019English

Phase II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer

The Internet Journal of Oncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy